You are here

anemia

Go or no go? Apellis and Heron head for the finish line

EP Vantage

Fri, 04/30/21 - 10:30 am

Heron Therapeutics

FibroGen shares take a beating as CEO reveals safety data manipulation for its blockbuster contender roxadustat

Endpoints

Tue, 04/6/21 - 11:13 pm

Akebia tries for FDA approval of anemia drug after mixed data

BioPharma Dive

Tue, 03/30/21 - 10:15 pm

Akebia Therapeutics

AstraZeneca, FibroGen's roxadustat hits snag at FDA, but analysts figure an approval's still on its way

Fierce Pharma

Mon, 12/21/20 - 11:46 pm

Agios' anemia drug hits goal in phase 3, teeing up 2021 filing

Fierce Biotech

Tue, 12/1/20 - 10:55 am

Agios Pharmaceuticals

GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival

Pharmaforum

Mon, 06/29/20 - 06:21 pm

chronic kidney disease

Astellas' Anemia Drug Roxadustat Shows Non-Inferiority to Amgen's Aranesp

BioSpace

Mon, 06/8/20 - 11:36 pm

clinical trials

chronic kidney disease

Akebia confirms its place in the anemia race

EP Vantage

Tue, 05/5/20 - 12:57 pm

clinical trials

CHMP backs BMS’ first-in-class anemia drug Reblozyl

Pharmaforum

Mon, 05/4/20 - 10:34 am

Bristol-Myers Squibb

Easing concerns, FibroGen, AstraZeneca secure FDA date for their anemia drug in broad chronic kidney disease population

Endpoints

Wed, 02/12/20 - 10:50 am

chronic kidney disease

FDA Approves Celgene and Acceleron's Treatment for Rare Blood Disease

BioSpace

Sat, 11/9/19 - 12:13 pm

beta thalassemia

Roxadustat safety analysis provokes more questions than answers

EP Vantage

Fri, 05/10/19 - 10:29 am

Pfizer launches biosimilar version of Amgen's Epogen

Biopharma Dive

Wed, 11/14/18 - 11:45 pm

Amgen falls short in Epogen patent appeal but Pfizer stumble delays competition

Fierce Pharma

Fri, 08/11/17 - 11:22 am

FDA Rejects Pfizer's Anemia Drug Biosimilar

Xtalks

Tue, 06/27/17 - 11:50 pm

FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson

Fierce Pharma

Mon, 05/29/17 - 12:00 pm

advisory panels

Pfizer's Epogen biosim scores solid backing from FDA staff ahead of panel review

Fierce Pharma

Wed, 05/24/17 - 10:51 am

advisory panels

GlaxoSmithKline Launches Anemia Drug Trial

Investopedia

Sun, 11/27/16 - 03:55 pm

clinical trials

Agios drug boosts hemoglobin in anemia patients in mid-stage trial

Bizjournals.com

Sun, 06/12/16 - 12:26 pm

clinical trials

Here’s the deal with Akebia’s anemia drug that caused a 50% stock hike today

Bizjournals.com

Wed, 09/9/15 - 10:02 pm

Akebia Therapeutics

Pages